肝素鈣市場：按類型、給藥途徑、應用、分銷管道和地區分類－市場規模、佔有率、前景和機會分析，2025-2032年

Heparin Calcium Market, by Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，肝素鈣市場規模將達到 15.281 億美元，到 2033 年將達到 18.666 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 2.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	15.281億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	2.90%	2033年市場規模預測：	18.666億美元

肝素鈣是肝素的鈣鹽。肝素鈣是一種帶負電荷的鎖狀多醣，屬於Glico類。肝素是一種抗凝血劑，用於預防和治療血栓事件，例如肺動脈栓塞、深層靜脈栓塞症和心房顫動。作為一種Glico抗凝血劑，肝素鈣與抗凝血酶III結合形成肝素-抗凝血酶III複合物。肝素也用於預防心血管手術和透析期間的過度凝血。肝素可經由靜脈注射或皮下注射給藥。肝素鈣有兩種形式：未分級肝素和低分子量肝素。皮下注射肝素用於預防血栓性栓塞症，靜脈注射肝素用於治療性抗凝血。長期使用肝素可導致出血、血小板減少性疾病、注射部位反應及其他副作用。出血是肝素使用的主要併發症之一。長期使用未分級肝素會增加骨質疏鬆的風險。未分級肝素比低分子肝素對凝血酶的特異性更高，其作用通常可用硫酸魚精蛋白逆轉。

市場動態

預計在預測期內，諸如開展宣傳宣傳活動等非有機成長策略的日益普及將推動全球肝素鈣市場成長。例如，2020年11月，百時美施貴寶和輝瑞宣布聯合發起「刻不容緩」宣傳宣傳活動，旨在提高大眾對深層靜脈栓塞症症狀的認知。該宣傳活動幫助人們獲取更多關於深層靜脈栓塞症的資訊。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球肝素鈣市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份全球肝素鈣市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球肝素鈣市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Sanofi
Pfizer Inc.
Dongying Tiandong Pharmaceutical Co., Ltd.
- Company Highlight
PANPHARMA SA
Merck KGaA
Teva Pharmaceutical Industries Ltd.
SMITHFIELD BIOSCIENCE
Afine Chemicals Limited
Yino Pharma Limited
Shandong Sheelian Pharmaceutical Co., Ltd.
Aspen Holdings
Opocrin SpA

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5483

Heparin Calcium Market is estimated to be valued at USD 1,528.1 Mn in 2026 and is expected to reach USD 1,866.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 2.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,528.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.90%	2033 Value Projection:	USD 1,866.6 Mn

Heparin calcium is calcium salt form of heparin. Heparin calcium is a negatively charged linear polysaccharide that belongs to the glycosaminoglycan family. Heparin is an anticoagulant which is indicated for the prevention and treatment of thrombotic events such as pulmonary embolism, deep vein thrombosis and atrial fibrillation. As a glycosaminoglycan anticoagulant, heparin calcium binds to antithrombin III to form a heparin-antithrombin III complex. Heparin is also used to prevent excess coagulation during cardiac surgery, dialysis, and others. Heparin can be administered by intravenous or subcutaneous route. Unfractionated heparin and low molecular weight heparin are the two forms of calcium heparin. Subcutaneous heparin is administred to prevent thromboembolism and the administration of intravenous heparin is used for therapeutic anticoagulation. Bleeding, thrombocytopenia, injection site reactions, and other adverse effects are seen with chronic heparin administration. Bleeding is a major complication associated with heparin use. In long term use, unfractionated heparin has a higher risk of osteoporosis. Unfractionated heparin is more specific than low molecular weight heparin for thrombin and the effects of unfractionated heparin can typically be reversed by using protamine sulfate.

Market Dynamics

Increasing adoption of inorganic strategies such as launch of campaign, in order to raise awareness is expected to drive the global heparin calcium market growth over the forecast period. For instance, in November 2020, The Bristol Myers Squibb-Pfizer Alliance, announced that they had launched the 'No Time to Wait' awareness campaign, to raise awareness of the symptoms of deep vein thrombosis. This campaign helps people to find additional information about deep vein thrombosis.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global heparin calcium market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global heparin calcium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heparin calcium market

Detailed Segmentation:

Global Heparin Calcium Market, By Type (Revenue, USD Mn, 2021 - 2033)
Unfractionated Heparin
Low Molecular Weight Heparin
Global Heparin Calcium Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
Intravenous
Subcutaneous
Global Heparin Calcium Market, By Application (Revenue, USD Mn, 2021 - 2033)
Kidney Dialysis
Atrial Fibrillation
Deep Vein Thrombosis
Pulmonary Embolism
Others (Cardiac Surgery, etc.)
Global Heparin Calcium Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Heparin Calcium Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country
  - U.S.
  - Canada
Latin America
- By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Regions
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Sanofi*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
Dongying Tiandong Pharmaceutical Co., Ltd.
PANPHARMA S.A.
Merck KGaA
Teva Pharmaceutical Industries Ltd.
SMITHFIELD BIOSCIENCE
Afine Chemicals Limited
Yino Pharma Limited
Shandong Sheelian Pharmaceutical Co., Ltd.
Aspen Holdings
Opocrin S.p.A.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Guidelines
Product launches
Key Development
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions

4. Global Heparin Calcium Market, By Type, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Unfractionated Heparin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Low Molecular Weight Heparin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Heparin Calcium Market, By Route of Administration, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Heparin Calcium Market, By Application, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Kidney Dialysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Atrial Fibrillation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Deep Vein Thrombosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Pulmonary Embolism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others (Cardiac Surgery, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Heparin Calcium Market, By Distribution Channel, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

8. Global Heparin Calcium Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Dongying Tiandong Pharmaceutical Co., Ltd.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PANPHARMA S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SMITHFIELD BIOSCIENCE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Afine Chemicals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Yino Pharma Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Shandong Sheelian Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aspen Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Opocrin S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies